NOVA SOUTHEASTERN UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1964-01-01
- Employees
- 4.5K
- Market Cap
- -
- Website
- http://www.nova.edu
Clinical Trials
73
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (63 trials with phase data)• Click on a phase to view related trials
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)Primary Lateral Sclerosis (PLS)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
- First Posted Date
- 2025-09-23
- Last Posted Date
- 2025-09-23
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 10
- Registration Number
- NCT07187388
- Locations
- 🇺🇸
Nova Southeastern University, David and Cathy Husman Neuroscience Institute, Davie, Florida, United States
Adolescent Suicide Loss Survivors Grief Intervention Group
- Conditions
- Grief
- First Posted Date
- 2025-09-03
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 20
- Registration Number
- NCT07151092
The Effects of Gyngerlean Supplementation on Energy Expenditure
- Conditions
- No Disease or Condition is Being StudiedMetabolism
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 10
- Registration Number
- NCT06805201
- Locations
- 🇺🇸
Nova Southeastern University, Davie, Florida, United States
Mitigating Response to Stressors in Pregnant Women
- Conditions
- Pregnancy
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 50
- Registration Number
- NCT06718907
- Locations
- 🇺🇸
Nova Southeastern University, Davie, Florida, United States
Magnesium Supplementation on Body Composition
- Conditions
- Body Composition Changes
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 12
- Registration Number
- NCT06703099
- Locations
- 🇺🇸
Nova Southeastern University HPD Annex Building, Davie, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
Early Long COVID Trials of Paxlovid and Monoclonal Antibodies Show No Significant Benefits, But Research Continues
Three prominent clinical trials testing Paxlovid and monoclonal antibodies for Long COVID failed to show significant health improvements compared to placebo groups.
Global Clinical Trial Launches to Test Sipavibart as Potential Long COVID Treatment
Nova Southeastern University researchers have begun a clinical trial testing AstraZeneca's monoclonal antibody sipavibart as a potential treatment for Long COVID, funded by the Schmidt Initiative for Long COVID.